Trial intelligence / Profile preview

Bimatoprost eyelash gel for chemotherapy-induced madarosis

NCT01200251Phase 3Completed

Sponsor
Duke University
Start
Feb 2007
Primary completion
Sep 2007
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of bimatoprost in madarosis, hypotrichosis, sponsored by Duke University. Started Feb 2007; status: completed.

02

Drugs

bimatoprost
03

Conditions

madarosishypotrichosis

Beyond the preview

Go deeper on NCT01200251.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01200251.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call